Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Mayako, Goto"'
Autor:
Roze Isono-Taniguchi, Mayako Goto, Yumi Takimoto, Tomoko Ueda, Yu Wakimoto, Kayo Inoue, Kensuke Hori, Kimihiko Ito, Hiroshi Tsubamoto
Publikováno v:
Gynecologic Oncology Reports, Vol 42, Iss , Pp 101013- (2022)
No standard chemotherapy is available after disease progression or anaphylaxis during platinum chemotherapy among patients with recurrent cervical cancer. Here we report the efficacy and toxicities of metronomic chemotherapy consisting of 50 mg of or
Externí odkaz:
https://doaj.org/article/90a327ecbd9b49e58a98e77b3a51d29d
Autor:
Terumi Tanigawa, Nobuhiro Takeshima, Hideki Ishikawa, Shin Nishio, Tomoka Usami, Takaharu Yamawaki, Tetsuro Oishi, Kei Ihira, Hisamori Kato, Mayako Goto, Motoaki Saito, Yusuke Taira, Masatoshi Yokoyama, Tadahiro Shoji, Eiji Kondo, Atsushi Mori, Takeshi Yokoi, Naomi Iwasa-Inoue, Yasuyuki Hirashima, Takayuki Nagasawa, Motoki Takenaka, Mikio Mikami, Toru Sugiyama, Takayuki Enomoto
Publikováno v:
Gynecologic Oncology. 165:413-419
This multicenter, open-label, phase II study aimed to evaluate the efficacy and safety of paclitaxel-carboplatin, bevacizumab, and bevacizumab-based maintenance therapy for metastatic, recurrent, and persistent uterine cervical cancer.Patients with m
Autor:
Kimihiko Ito, Mio Nakagawa, Mototsugu Shimokawa, Kensuke Hori, Lena Tashima, Mayako Goto, Satoshi Yanagida, Jiro Suzuki, Ryusuke Kaya, Ayako Kawabata, Kyosuke Yamada, Jongmyung Park, Hiroki Nasu, Shin Nishio, Eiji Kondo, Michiko Kaneda, Hiroshi Tsubamoto, Atsushi Arakawa, Takayuki Nagasawa, Takashi Motohashi
Publikováno v:
Anti-Cancer Drugs; Aug2023, Vol. 34 Issue 7, p857-865, 9p
Autor:
Kimihiko Ito, Mio Nakagawa, Mototsugu Shimokawa, Kensuke Hori, Lena Tashima, Mayako Goto, Satoshi Yanagida, Jiro Suzuki, Ryusuke Kaya, Ayako Kawabata, Kyosuke Yamada, Jongmyung Park, Hiroki Nasu, Shin Nishio, Eiji Kondo, Michiko Kaneda, Hiroshi Tsubamoto, Atsushi Arakawa, Takayuki Nagasawa, Takashi Motohashi
Publikováno v:
Anti-Cancer Drugs.
Autor:
Mayako Goto, Hiroshi Tsubamoto, Roze Isono-Taniguchi, Yumi Takimoto, Lena Tashima, Kensuke Hori, Kimihiko Ito
Publikováno v:
Medicine. 102:e32880
Autor:
Mio, Nakagawa, Kimihiko, Ito, Kiri, Uragami, Junko, Suzuki, Mayu, Shiomi, Hitomi, Ono, Kanoko, Shimoji, Michiko, Yamashita, Masayo, Onoue, Emi, Yoshioka, Mayako, Goto, Lena, Tashima, Kensuke, Hori
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 48(3)
Ovarian clear cell carcinoma(OCCC)shows a poor response to standard chemotherapy, and it is often difficult to choose a regimen for patients with recurrent OCCC. Several reports have suggested a synergistic effect between gemcitabine and cisplatin; a
Autor:
Tomohiko, Takei, Erika, Takaki, Saori, Tsuji, Masayo, Onoue, Michiko, Yamashita, Emi, Yoshioka, Mayako, Goto, Lina, Tashima, Kimihiko, Ito, Kensuke, Hori
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(10)
We reviewed our clinical experience of olaparib treatment for patients with platinum-sensitive recurrent ovarian, fallopian tube, and peritoneal cancer. Of the 10 cases, the primary sites of cancer were the ovaries, fallopian tubes, and peritoneum in
Publikováno v:
BMJ Case Rep
Intra-abdominal bleeding due to uterine fibroids is extremely rare, and preoperative diagnosis is difficult. Herein, we report a case of preoperatively diagnosed hypovolaemic shock due to intra-abdominal haemorrhage, in which fatal sequelae were prev
Autor:
Susumu Yoshida, Ayaka Nakashima, Mai Nishimura, Mayako Goto, Kayoko Shikado, Takuya Kushimoto, Osamu Sato, Kazuhide Ogita
Publikováno v:
Open Journal of Obstetrics and Gynecology. :808-812
Objectives: Preeclampsia is a major cause of maternal and perinatal morbidity and mortality. Early diagnosis of preeclampsia is important to help patients with preeclampsia. However, 24-hour urine collection is the gold standard diagnostic method at
Autor:
Kanoko, Shimoji, Kimihiko, Ito, Lena, Tashima, Tomohiko, Tsuruta, Mio, Nakagawa, Yoshinori, Kagawa, Yutaka, Takeda, Takashi, Iwata, Taro, Yagi, Chihiro, Odani, Hitomi, Ono, Rieko, Okubo, Mayako, Goto, Kensuke, Hori
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 44(8)
The current standard treatment for advanced ovarian cancer is primary debulking surgery(PDS). We may expect a good prognosis if complete debulking(no visible residual tumor)is possible. However, if complete surgery is not possible owing to the locati